Working at Inserm Transfert involves supporting the transfer of human health innovation in economic, clinical and societal terms by incorporating a dynamic expert company of a human scale.
This also means engaging with a company that is developing its expertise both in France and internationally.
Finally, we are at the service of Inserm, the first European biomedical research body and the only French public research organisation to be wholly dedicated to human health.
Inserm Transfert implements a Human Resources policy that is designed to support workers in constructing and enriching their occupational pathway. It directs them towards ambitious projects in a relaxed and friendly work environment, in which each worker is able to bring his/her contribution and develop both as an individual person and as a team player.
We are convinced that the success of each partner leads to the success of the company and helps it to thrive.
We regularly recruit qualified experts in business/health law, patent engineers, patent assistants, business development managers, project leads for constructing collaborative and/or scientific projects and more.
GENDER EQUALITY INDEX 2025.
INSERM TRANSFERT RECEIVES A SCORE OF 81/100 (1)
For several years, Inserm Transfert has implemented policies and steering indicators in the area of professional equality, enabling it to ensure equal treatment between women and men.
For the year 2025, maximum scores were achieved on three of the four indicators used to calculate the Professional Equality Index.
However, the age pyramid of our workforce for that same year did not allow us to achieve a satisfactory score on one of the indicators. Thus, the overall Equality Index score calculated for 2025 is 81/100.
To increase this index, Inserm Transfert is committed to strengthening its policies based on three areas: professional training, effective remuneration, and the balance between professional and personal life.
Inserm Transfert is determined to continue its process of continuous improvement and is continuing its consultation with staff representatives and employees with the aim of increasing this score.
(1) Index calculated for the 2025 period
You wish to submit a unsolicited application
Our professional expertise
The principal mission of the legal department is to draft contracts based on the Inserm Transfert’s contractual standards. They also review contracts sent or amended by industrial or institutional partners. The missions within Inserm Transfert are the following: Drawing up and reviewing contracts, participation in or conducting of negotiations, specific consultations on particular subjects, participation in litigation and pre-litigation and company law.
The Collaborative Research Funding team provides support to applicants in various collaborative research projects and industrial partnerships tender offers, thus throughout the project lifecycle. They also manage Inserm’s transverse programmes and support the long term sustainability of structuring projects run by Inserm.
Inserm Transfert experts are in almost permanent contact with Inserm researchers. Their aim is to identify innovations by visiting the Inserm laboratories and then assessing their maturation and value creation potential. It supports them in their approaches used to protect their results—particularly in terms of submission of patents—offers them advice and directs them, if needed, towards other technologies or expertise.
In conjunction with researchers or companies, our specialists work towards project development in order to increase their maturity or their value. Inserm has provided us with a maturation package, which we invest in high-potential projects. We are also involved in finding other sources of funding for project development.
The mission of the Industrial Parnerships & Entrepreneurship team, through the 4 activities (R&D Collaboration, Licensing & Entrepreneurship, Health Data and Clinical Research, Alliance Management and Major Alliances) is to promote the results, expertise, databases, innovations and technologies, whether patented or not, from Inserm laboratories to industrial players or investors so that they can be put to use in healthcare. Therefore, their role is to study the industrial and technological overview of Inserm's strategic themes and, depending on the results, to position Inserm Transfert's various innovations on the market. They also handle negotiations with industrialists as well as the implementation of licence agreements, public/private projects and partnerships.